Alveolar Surface Tension Reduction [PE]: Side Effects & Safety Data for 2 Drugs
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
Alveolar Surface Tension Reduction [PE] includes 2 drugs with a combined 605 adverse event reports in the FDA FAERS database. Compare their safety profiles, side effects, and outcomes below.
2
Drugs in Class
605
Combined Reports
All Alveolar Surface Tension Reduction [PE] Drugs Ranked by Reports
| Drug | Brand Name | Reports | Deaths | Hosp. | Death Rate |
|---|---|---|---|---|---|
| PORACTANT ALFA | Curosurf | 564 | 168 | 44 | 29.8% |
| CALFACTANT | INFASURF | 41 | 6 | 5 | 14.6% |
Common Side Effects in Alveolar Surface Tension Reduction [PE] Drugs
| Side Effect | Reports | Deaths |
|---|---|---|
| Neonatal hypoxia | 118 | 6 |
| Off label use | 71 | 17 |
| Endotracheal intubation complication | 50 | 5 |
| Ill-defined disorder | 48 | 41 |
| Bradycardia neonatal | 45 | 6 |
| Pulmonary haemorrhage | 38 | 27 |
| Drug ineffective | 34 | 11 |
| Product complaint | 31 | 5 |
| Infantile apnoea | 30 | 1 |
| Pulmonary haemorrhage neonatal | 27 | 12 |